ATC code H05
ATC code H05 Calcium homeostasis is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup H05 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[4]
| ATC code H: Systemic hormonal preparations, excluding sex hormones and insulins |
|---|
|
| Other ATC codes |
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH05.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
H05A Parathyroid hormones and analogues
H05AA Parathyroid hormones and analogues
- H05AA01 Parathyroid gland extract
- H05AA02 Teriparatide
- H05AA03 Parathyroid hormone
- H05AA04 Abaloparatide
H05B Anti-parathyroid agents
H05BA Calcitonin preparations
H05BX Other anti-parathyroid agents
- H05BX01 Cinacalcet
- H05BX02 Paricalcitol
- H05BX03 Doxercalciferol
- H05BX04 Etelcalcetide
- H05BX05 Calcifediol
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code H05". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QH05". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.